(Pictured: Dr. Toby Cornish, Dr. Michael Clay, Dr. Lauren Fishbein, Dr. Jena Demedis, Dr. Bennett Chin, Dr. Daniel Bowels)
Pheo Para Alliance (PPA) has designated University of Colorado as a Pheo Para Research & Clinical Center of Excellence. This designation is provided to centers which have a comprehensive research program and provide high-quality, multi-disciplinary care for pheochromocytoma and paraganglioma patients.
Linda Rose-Krasnor, Chair of the PPA Board of Directors states, “It is exciting to recognize University of Colorado’s comprehensive multi-disciplinary pheo and para team under the leadership of Dr. Lauren Fishbein. Dr. Fishbein’s contributions in the areas of research, patient education and clinical care are extraordinary. Sharing this center’s expertise with our patient population will undoubtedly provide patients in the region with the best possible health outcomes.”
This announcement brings the total list of designated Centers of Excellence to fifteen. This is the fourth center recognized as a Research & Clinical Center of Excellence.
About University of Colorado
The University of Colorado Anschutz Medical Campus is at the forefront of health sciences research, education and patient care. With over 2 million patient visits annually, the medical providers at UCHealth University of Colorado and Children’s Hospital of Colorado are focused on patient health and well-being as well as strengthening partnerships in the community. In addition, across the campus, there are collaborations in research and innovation to pursue new frontiers in healthcare and education.
Learn more about the Pheo Para Alliance Center of Excellence Program here.